{
    "success": true,
    "data": {
        "leverage": false,
        "derivatives": true,
        "swaps": true,
        "inverse": false,
        "replication_method": "synthetic",
        "ucits": false,
        "type": "ETP",
        "complex_factors": [
            "Product is a Tracker Certificate, which is a structured product with a derived payoff.",
            "The product's payoff is linked to a commodity index, implying synthetic replication via derivatives/swaps, which introduces counterparty risk and requires advanced understanding of how the payoff is achieved without direct ownership.",
            "The product explicitly states 'You will not have any rights of ownership... with respect to the Underlying,' confirming synthetic exposure.",
            "The KID includes a mandatory comprehension alert: 'You are about to purchase a product that is not simple and may be difficult to understand,' indicating the manufacturer's own complex assessment.",
            "The product is for clients with 'advanced knowledge of and/or experience with financial products,' not for a retail investor with basic knowledge.",
            "It is not a UCITS, therefore, the presumption of non-complexity does not apply; it must be assessed against MiFID II Delegated Regulation EU 2017/565 Article 57 (or the prior Article 38 of Level 2 Directive).",
            "The product falls under MiFID Level 1 Art. 4(1)(18)(c) as a security giving rise to a cash settlement determined by reference to an index, which automatically classifies it as complex under Article 38(a) of the Level 2 Directive (CESR/09-295, Section 4, para 90, 91)."
        ],
        "classification": "complex",
        "supporting_data": "This product is a 'Tracker Certificate' and not a UCITS ETF, thus the UCITS presumption of non-complexity does not apply. Its structure explicitly states that the redemption amount is linked to the 'Settlement Price of the Underlying... multiplied by the Multiplier,' without the investor holding any ownership rights to the underlying assets. This indicates a synthetic replication method, which inherently relies on derivative instruments (such as total return swaps or contracts for difference) to achieve its investment objective. The use of such instruments, integral to the product's strategy rather than for efficient portfolio management, introduces risks like counterparty risk (explicitly mentioned as 'You are exposed to the risk that the Issuer might be unable to fulufb01l its obligations... in the event of insolvency').Crucially, the Key Information Document itself contains a prominent 'You are about to purchase a product that is not simple and may be difficult to understand' alert, which, as per the MiFID II rules, is a mandatory warning for complex products. Furthermore, the product is described as suitable for 'clients with advanced knowledge of and/or experience with financial products,' clearly indicating it is not easily understood by an average retail investor. Under MiFID II, specifically Article 38(a) of the Level 2 Directive (CESR/09-295, Section 4, para 90, 91), any financial instrument that falls within Article 4(1)(18)(c) of MiFID Level 1 (which includes securities giving rise to a cash settlement determined by reference to commodities or other indices or measures, as is the case here with the UBS CMCI Aluminium USD TR Index) is automatically considered complex and cannot meet the criteria for non-complex classification."
    }
}